2018-2025 Gastrointestinal Stromal Tumor (GIST) Drug Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

March 2018 | 120 pages | ID: 2CCF0716C25EN
QYResearch

Abstracts

SUMMARY

This report studies the Gastrointestinal Stromal Tumor (GIST) Drug market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Gastrointestinal Stromal Tumor (GIST) Drug market by product type and application/end industries.

The global Gastrointestinal Stromal Tumor (GIST) Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gastrointestinal Stromal Tumor (GIST) Drug.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Gastrointestinal Stromal Tumor (GIST) Drug in these regions, from 2013 to 2025 (forecast), covering

• United States
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

The major players in global and United States market, including

• Ariad Pharmaceuticals, Inc.
• Arog Pharmaceuticals, Inc.
• Array BioPharma Inc.
• Astex Pharmaceuticals, Inc.
• Blueprint Medicines Corporation
• Boston Biomedical, Inc.
• Calithera Biosciences, Inc.
• Chipscreen Biosciences Ltd
• Deciphera Pharmaceuticals, LLC
• F. Hoffmann-La Roche Ltd.
• Horizon Pharma Plc
• Immunicum AB
• Jiangsu Hengrui Medicine Co., Ltd.
• Kolltan Pharmaceuticals, Inc.
• Natco Pharma Limited
• Nerviano Medical Sciences S.r.l.
• Novartis AG
• Omeros Corporation

On the basis of product, the market is primarily split into

• Amcasertib
• Anagrelide hydrochloride CR
• APG-1351
• Binimetinib
• Others

On the basis on the end users/application, this report covers

• Clinic
• Hospital
• Others

Contents

2018-2025 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG REPORT ON GLOBAL AND UNITED STATES MARKET, STATUS AND FORECAST, BY PLAYERS, TYPES AND APPLICATIONS

1 METHODOLOGY AND DATA SOURCE

1.1 Methodology/Research Approach
  1.1.1 Research Programs/Design
  1.1.2 Market Size Estimation
  1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
  1.2.1 Secondary Sources
  1.2.2 Primary Sources
1.3 Disclaimer

2 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET OVERVIEW

2.1 Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
2.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Segment by Type
  2.2.1 Amcasertib
  2.2.2 Anagrelide hydrochloride CR
  2.2.3 APG-1351
  2.2.4 Binimetinib
  2.2.5 Others
2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Product Segment by Type
  2.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
  2.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Market Share (%) by Type (2013-2018)
  2.3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Market Share (%) by Type (2013-2018)
  2.3.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Type (2013-2018)
2.4 United States Gastrointestinal Stromal Tumor (GIST) Drug Product Segment by Type
  2.4.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
  2.4.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Market Share by Type (2013-2018)
  2.4.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Market Share by Type (2013-2018)
  2.4.4 United States Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Type (2013-2018)

3 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG APPLICATION/END USERS

3.1 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Application/End Users
  3.1.1 Clinic
  3.1.2 Hospital
  3.1.3 Others
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Product Segment by Application
  3.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)
3.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Product Segment by Application
  3.3.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.3.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)

4 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET STATUS AND OUTLOOK BY REGIONS

4.1 Global Market Status and Outlook by Regions
  4.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size and CAGR by Regions (2013, 2017 and 2025)
  4.1.2 North America
  4.1.3 Asia-Pacific
  4.1.4 Europe
  4.1.5 South America
  4.1.6 Middle East and Africa
  4.1.7 United States
4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue by Regions
  4.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
  4.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
  4.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.4 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.5 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.6 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.7 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
  4.2.8 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.9 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

5 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS

5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Market Share by Players (2013-2018)
5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Pcs) by Players (2013-2018)
5.4 Global Top Players Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base Distribution, Sales Area, Product Types
5.5 Gastrointestinal Stromal Tumor (GIST) Drug Market Competitive Situation and Trends
  5.5.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Concentration Rate
  5.5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share (%) of Top 3 and Top 5 Players
  5.5.3 Mergers & Acquisitions, Expansion

6 UNITED STATES GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS

6.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Market Share by Players (2013-2018)
6.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Pcs) by Players (2013-2018)
6.4 United States Gastrointestinal Stromal Tumor (GIST) Drug Market Share (%) of Top 3 and Top 5 Players

7 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

7.1 Ariad Pharmaceuticals, Inc.
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.1.4 Main Business/Business Overview
7.2 Arog Pharmaceuticals, Inc.
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.2.4 Main Business/Business Overview
7.3 Array BioPharma Inc.
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.3.4 Main Business/Business Overview
7.4 Astex Pharmaceuticals, Inc.
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.4.4 Main Business/Business Overview
7.5 Blueprint Medicines Corporation
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.5.4 Main Business/Business Overview
7.6 Boston Biomedical, Inc.
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.6.4 Main Business/Business Overview
7.7 Calithera Biosciences, Inc.
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Chipscreen Biosciences Ltd
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.8.4 Main Business/Business Overview
7.9 Deciphera Pharmaceuticals, LLC
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.9.4 Main Business/Business Overview
7.10 F. Hoffmann-La Roche Ltd.
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.10.4 Main Business/Business Overview
7.11 Horizon Pharma Plc
7.12 Immunicum AB
7.13 Jiangsu Hengrui Medicine Co., Ltd.
7.14 Kolltan Pharmaceuticals, Inc.
7.15 Natco Pharma Limited
7.16 Nerviano Medical Sciences S.r.l.
7.17 Novartis AG
7.18 Omeros Corporation

8 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MANUFACTURING COST, INDUSTRIAL CHAIN AND DOWNSTREAM BUYERS

8.1 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain Analysis
8.4 Downstream Buyers in United States

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS AND MARKET EFFECT FACTORS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
  9.3.1 Economic/Political Environmental Change
  9.3.2 Downstream Demand Change
  9.3.3 Technology Progress in Related Industry
  9.3.4 Substitutes Threat

10 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET FORECAST

10.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue Forecast (2018-2025)
  10.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast
  10.2.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.2.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Regions
  10.3.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.3 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.4 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.5 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.4 Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Type
  10.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
  10.4.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Application
  10.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) Forecast by Application (2018-2025)
  10.5.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION



The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Gastrointestinal Stromal Tumor (GIST) Drug Product Picture
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of Amcasertib
Table Major Players of Amcasertib
Figure Global Amcasertib Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Anagrelide hydrochloride CR
Table Major Players of Anagrelide hydrochloride CR
Figure Global Anagrelide hydrochloride CR Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of APG-1351
Table Major Players of APG-1351
Figure Global APG-1351 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Binimetinib
Table Major Players of Binimetinib
Figure Global Binimetinib Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Pcs) and Growth Rate (%)(2013-2018)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Type (2013-2018)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share (%) by Type (2013-2018)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share (%) by Type (2013-2018)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share (%) by Type in 2017
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) by Type (2013-2018)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share (%) by Type (2013-2018)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (%) by Type
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Type (2013-2018)
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Type (2013-2018)
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Share (%) by Type (2013-2018)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share (%) by Type (2013-2018)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share (%) by Type in 2017
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) by Type (2013-2018)
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share (%) by Type (2013-2018)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share (%)by Type (2013-2018)
Figure 2017 United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (%) by Type
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Type (2013-2018)
Figure Clinic Examples
Figure Hospital Examples
Figure Others Examples
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) Comparison by Application (2013-2025)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Application (2013-2018)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share (%) by Application (2013-2018)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share (%) by Application (2013-2018)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share (%) by Application in 2017
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) Comparison by Application (2013-2025)
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Application (2013-2018)
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Share (%) by Application (2013-2018)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share (%) by Application (2013-2018)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share (%) by Application in 2017
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Regions (2013-2018)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share (%) by Regions (2013-2018)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share (%) by Regions
Figure 2017 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share (%) in Global Market
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) by Regions (2013-2018)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (%) by Regions (2013-2018)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (%) by Regions
Figure 2017 United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (%) in Global Market
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) of Key Players (2013-2018)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share (%) by Players (2013-2018)
Figure 2017 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share (%) by Players
Figure 2018 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share (%) by Players
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) by Players (2013-2018)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share (%) by Players (2013-2018)
Table 2017 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share (%) by Players
Table 2018 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share (%) by Players
Table Global Market Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Pcs) by Players (2013-2018)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Top Players Manufacturing Base Distribution and Sales Area
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Top Players Product Category
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share (%) of Top 3 Players
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share (%) of Top 5 Players
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Players (2013-2018)
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Share (%) by Players
Figure 2018 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Share (%) by Players
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) by Players (2013-2018)
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share (%) by Players
Table 2018 United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share (%) by Players
Table United States Market Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Pcs) by Players (2013-2018)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Market Share (%) of Top 3 Players
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Market Share (%) of Top 5 Players
Table Ariad Pharmaceuticals, Inc. Basic Information List
Table Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2013-2018)
Figure Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Global Market Share (%)(2013-2018)
Figure Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Global Market Share (%)(2013-2018)
Table Arog Pharmaceuticals, Inc. Basic Information List
Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2013-2018)
Figure Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Global Market Share (%)(2013-2018)
Figure Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Global Market Share (%)(2013-2018)
Table Array BioPharma Inc. Basic Information List
Table Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2013-2018)
Figure Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Global Market Share (%)(2013-2018)
Figure Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Global Market Share (%)(2013-2018)
Table Astex Pharmaceuticals, Inc. Basic Information List
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2013-2018)
Figure Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Global Market Share (%)(2013-2018)
Figure Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Global Market Share (%)(2013-2018)
Table Blueprint Medicines Corporation Basic Information List
Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2013-2018)
Figure Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales Global Market Share (%)(2013-2018)
Figure Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Revenue Global Market Share (%)(2013-2018)
Table Boston Biomedical, Inc. Basic Information List
Table Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2013-2018)
Figure Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Global Market Share (%)(2013-2018)
Figure Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Global Market Share (%)(2013-2018)
Table Calithera Biosciences, Inc. Basic Information List
Table Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2013-2018)
Figure Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales Global Market Share (%)(2013-2018)
Figure Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Global Market Share (%)(2013-2018)
Table Chipscreen Biosciences Ltd Basic Information List
Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2013-2018)
Figure Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales Global Market Share (%)(2013-2018)
Figure Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Revenue Global Market Share (%)(2013-2018)
Table Deciphera Pharmaceuticals, LLC Basic Information List
Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2013-2018)
Figure Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales Global Market Share (%)(2013-2018)
Figure Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Revenue Global Market Share (%)(2013-2018)
Table F. Hoffmann-La Roche Ltd. Basic Information List
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales Global Market Share (%)(2013-2018)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Global Market Share (%)(2013-2018)
Table Horizon Pharma Plc Basic Information List
Table Immunicum AB Basic Information List
Table Jiangsu Hengrui Medicine Co., Ltd. Basic Information List
Table Kolltan Pharmaceuticals, Inc. Basic Information List
Table Natco Pharma Limited Basic Information List
Table Nerviano Medical Sciences S.r.l. Basic Information List
Table Novartis AG Basic Information List
Table Omeros Corporation Basic Information List
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastrointestinal Stromal Tumor (GIST) Drug
Figure Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain Analysis
Table Major Buyers of Gastrointestinal Stromal Tumor (GIST) Drug
Table Distributors/Traders List
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States Gastrointestinal Stromal Tumor (GIST) DrugGastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) Forecast by Regions (2018-2025)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (Million USD) Forecast by Type (2018-2025)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share (%) Forecast by Type (2018-2025)
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Application (2018-2025)
Table United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Application (2018-2025)